The 2014 program will be dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke. This year’s conference will focus on preclinical and clinical studies and their paths toward optimizing outcomes. The most promising molecular, cellular, and tissue products will be presented. Presentations of key activities at state, federal, and international levels will be highlighted as measures of the progress ahead.
Leaders from the international community will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies.